Medifast, Inc.: reports 3rd quarter 2026 results

What happened

• On Oct 26, 2026, Medifast, Inc. issued a press release announcing its earnings for the 3rd quarter ended Sep 30, 2026. The press release is furnished as Exhibit 99.1 and is incorporated by reference in the report. The filing states this information is being furnished and shall not be deemed to be "filed" for any purpose, including Section 18 of the Exchange Act.

Key details

• Item reported: 2.02 Results of operations and financial condition (press release announcing earnings).
• Exhibit provided: 99.1 (press release announcing 3rd quarter 2026 results).
• Filing date and signature: report filed Oct 26, 2026 and signed by James P. Maloney, Chief Financial Officer.
• The filing includes Item 9.01 (financial statements and exhibits) to list the exhibit.

Why it may matter

• The filing reports results of operations under Item 2.02, which covers the company issuing an earnings press release for the 3rd quarter ended Sep 30, 2026; Exhibit 99.1 contains the press release. This filing does not show why the insider traded or why the company acted.